Development of Mirror-Image VHHs with Less Immunogenicity

Explore the cutting-edge research in "Development of Mirror-Image VHHs with Less Immunogenicity," authored by experts in the field and published by Springer Nature Switzerland AG in 2025. This insightful hardback spans 116 pages and delves into the innovative chemical synthesis of therapeutic targets, focusing on the screening process for novel mirror-image single-domain antibodies (D-VHH). The book provides a comprehensive overview of the chemical synthesis of model VHHs, detailing the unique characteristics of both enantiomeric VHHs, including their binding activity, biodistribution, and immunogenicity. Ideal for researchers and practitioners in biotechnology and pharmaceutical sciences, this book presents valuable findings that could pave the way for the development of less immunogenic therapeutic antibodies. Enhance your understanding of this vital area of study and stay ahead in the rapidly evolving field of immunology.